“Treatment With Tralokinumab Improves Health-Related Quality of Life in Adult Patients With Moderate to Severe Atopic Dermatitis: Results from a Phase 2b, Randomised, Double-Blind, Placebo-Controlled Study”. SKIN The Journal of Cutaneous Medicine 2 (December 17, 2018): S64. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/460.